Skip to main navigation Skip to search Skip to main content

Interim analysis of epidermal-growth factor receptor (EGFR) expression in a single-arm, phase II, first-line study (20060314) of panitumumab with FOLFIRI in the management of metastatic colorectal cancer (mCRC)

C. Koehne, R. Hofheinz, L. Mineur, H. Letocha, R. Greil, J. Thaler, E. Gamelin, Eva Fernebro, L. Wright, M. Karthaus

Research output: Contribution to journal › Published meeting abstract › peer-review

Original languageEnglish
Pages (from-to)343-344
JournalEJC Supplements
Volume7
Issue number2
Publication statusPublished - 2009
Event15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology - Berlin, Germany
Duration: 2009 Sept 20 → 2009 Sept 24

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Subject classification (UKÄ)

  • Cancer and Oncology

Cite this